---
title: Pharma Medica Research Inc. vs YPrime
slug_a: pharmamedica
slug_b: yprime
site: cro
review_signal_gate: closed
canonical_path: /compare/pharmamedica/yprime
generated_by: BioBM Editorial AI
---

# Pharma Medica Research Inc. vs YPrime

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Pharma Medica Research Inc. (pharmamedica) is listed for cro. Canadian CRO running early-phase clinical trials from a 24-bed Phase I unit, with in-house bioanalysis under a 21 CFR Part 11-compliant laboratory data management system. Its scientific affairs team supports protocol design, biostatistics, and submission-ready reports.

Services: 8. Modalities: 0. Indications: 0. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (8).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

YPrime (yprime) is listed for cro. YPrime delivers configurable eCOA, IRT, and eConsent clinical trial technology platforms with consulting services, supporting ~1,000 studies globally across 19+ therapeutic areas.

Services: 10. Modalities: 0. Indications: 7. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (10).

Review summary: Review summary withheld until site-level review gate opens.